Hidradenitis suppurativa: are tumour necrosis factor-α blockers the ultimate alternative?
- 1 September 2008
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 159 (3) , 761-763
- https://doi.org/10.1111/j.1365-2133.2008.08735.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated casesInternational Journal of Dermatology, 2007
- Long-term efficacy of a single course of infliximab in hidradenitis suppurativaBritish Journal of Dermatology, 2007
- Infliximab for the Treatment of Hidradenitis SuppurativaDermatology, 2007
- Infliximab for severe hidradenitis suppurativa: Transient clinical efficacy in 7 consecutive patientsJournal of the American Academy of Dermatology, 2007
- Variable response of hidradenitis suppurativa to infliximab in four patientsClinical and Experimental Dermatology, 2006
- Long-term infliximab for severe hidradenitis suppurativaBritish Journal of Dermatology, 2006
- Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativaBritish Journal of Dermatology, 2003
- Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patientAmerican Journal of Gastroenterology, 2002
- Morbidity in patients with hidradenitis suppurativaBritish Journal of Dermatology, 2001